Morita N, Harada M, Uno M, Matsubara S, Matsuda T, Nagahiro S, et al. Ischemic findings of T2*-weighted 3-tesla MRI in acute stroke patients. Cerebrovasc Dis. 2008;26:367–75.
Ogawa S, Lee TM, Nayak AS, Glynn P. Oxygenation-sensitive contrast in magnetic resonance image of rodent brain at high magnetic fields. Magn Reson Med. 1990;14:68–78.
Article CAS PubMed Google Scholar
Horie N, Morikawa M, Nozaki A, Hayashi K, Suyama K, Nagata I. “Brush sign” on susceptibility-weighted MR imaging indicates the severity of Moyamoya disease. AJNR Am J Neuroradiol. 2011;32:1697–702.
Article CAS PubMed PubMed Central Google Scholar
Aguiar de Sousa D, Lucas Neto L, Jung S, Penas S, Panos L, Heldner MR, et al. Brush sign is associated with increased severity in cerebral venous thrombosis. Stroke. 2019;50:1574–7.
Hakim A, Aguiar de Sousa D. Brush sign in Sturge-Weber syndrome. Pediatr Radiol. 2018;48:895–6.
Okudera T, Huang YP, Fukusumi A, Nakamura Y, Hatazawa J, Uemura K. Micro-angiographical studies of the medullary venous system of the cerebral hemisphere. Neuropathology. 1999;19:93–111.
Article CAS PubMed Google Scholar
Haacke EM, Xu Y, Cheng YC, Reichenbach JR. Susceptibility weighted imaging (SWI). Magn Reson Med. 2004;52:612–8.
Haller S, Haacke EM, Thurnher MM, Barkhof F. Susceptibility-weighted imaging: technical essentials and clinical neurologic applications. Radiology. 2021;299:3–26.
Reichenbach JR, Jonetz-Mentzel L, Fitzek C, Haacke EM, Kido DK, Lee BC, et al. High-resolution blood oxygen-level dependent MR venography (HRBV): a new technique. Neuroradiology. 2001;43:364–9.
Article CAS PubMed Google Scholar
Rauscher A, Sedlacik J, Barth M, Mentzel HJ, Reichenbach JR. Magnetic susceptibility-weighted MR phase imaging of the human brain. AJNR Am J Neuroradiol. 2005;26:736–42.
PubMed PubMed Central Google Scholar
Jiang HF, Zhang YQ, Pang JX, Shao PN, Qiu HC, Liu AF, et al. Factors associated with prominent vessel sign on susceptibility-weighted imaging in acute ischemic stroke. Sci Rep. 2021;11:5641.
Article CAS PubMed PubMed Central Google Scholar
Wang Y, Shi T, Chen B, Lin G, Xu Y, Geng Y. Prominent hypointense vessel sign on susceptibility-weighted imaging is associated with clinical outcome in acute ischaemic stroke. Eur Neurol. 2018;79:231–9.
Mucke J, Möhlenbruch M, Kickingereder P, Kieslich PJ, Bäumer P, Gumbinger C, et al. Asymmetry of deep medullary veins on susceptibility weighted MRI in patients with acute MCA stroke is associated with poor outcome. PLoS ONE. 2015;10:e0120801.
Article PubMed PubMed Central Google Scholar
Zhang X, Zhang S, Chen Q, Campbell BCV, Lou M. Ipsilateral prominent thalamostriate vein on susceptibility-weighted imaging predicts poor outcome after intravenous thrombolysis in acute ischemic stroke. AJNR Am J Neuroradiol. 2017;38:875–81.
Article CAS PubMed PubMed Central Google Scholar
Dejobert M, Cazals X, Annan M, Debiais S, Lauvin MA, Cottier JP. Susceptibility-diffusion mismatch in hyperacute stroke: correlation with perfusion-diffusion mismatch and clinical outcome. J Stroke Cerebrovasc Dis. 2016;25:1760–6.
Yu J, Wang L, Li Z, Wang S, Wang G. Related factors of asymmetrical vein sign in acute middle cerebral artery stroke and correlation with clinical outcome. J Stroke Cerebrovasc Dis. 2017;26:2346–53.
Luo Y, Gong Z, Zhou Y, Chang B, Chai C, Liu T, et al. Increased susceptibility of asymmetrically prominent cortical veins correlates with misery perfusion in patients with occlusion of the middle cerebral artery. Eur Radiol. 2017;27:2381–90.
Verma RK, Hsieh K, Gratz PP, Schankath AC, Mordasini P, Zubler C, et al. Leptomeningeal collateralization in acute ischemic stroke: impact on prominent cortical veins in susceptibility-weighted imaging. Eur J Radiol. 2014;83:1448–54.
Park MG, Yang TI, Oh SJ, Baik SK, Kang YH, Park KP. Multiple hypointense vessels on susceptibility-weighted imaging in acute ischemic stroke: surrogate marker of oxygen extraction fraction in penumbra? Cerebrovasc Dis. 2014;38:254–61.
Article CAS PubMed Google Scholar
Jiang L, Sui B, Shen M, Qin H, Gao P. Are prominent medullary veins better than prominent cortical veins as predictors of early clinical outcome in patients with acute ischemic stroke? Diagn Interv Radiol. 2021;27:285–92.
Jensen-Kondering U, Böhm R. Asymmetrically hypointense veins on T2*w imaging and susceptibility-weighted imaging in ischemic stroke. World J Radiol. 2013;5:156–65.
Article PubMed PubMed Central Google Scholar
Kim YW, Choi YY, Park SY, Kim HJ, Kim YS. Prominent hypointense vessel on susceptibility-weighted images accompanying hyperacute and acute large infarction. Jpn J Radiol. 2021;39:681–9.
Article CAS PubMed Google Scholar
Bu J, Han X, Wu Y, Lv H, Feng X, Gao D. Correlation between asymmetrical vein sign of SWI and long-term clinical outcomes in patients with middle cerebral artery ischemic stroke. Jpn J Radiol. 2024;42:1122–9.
Terasawa Y, Yamamoto N, Morigaki R, Fujita K, Izumi Y, Satomi J, et al. Brush sign on 3-T T2*-weighted MRI as a potential predictor of hemorrhagic transformation after tissue plasminogen activator therapy. Stroke. 2014;45:274–6.
Article CAS PubMed Google Scholar
Xie S. MR OEF imaging in MELAS. Methods Enzymol. 2014;547:433–44.
Guenego A, Leipzig M, Fahed R, Sussman ES, Faizy TD, Martin BW, et al. Effect of oxygen extraction (brush-sign) on baseline core infarct depends on collaterals (HIR). Front Neurol. 2021;11:618765.
Article PubMed PubMed Central Google Scholar
Guenego A, Mlynash M, Christensen S, Kemp S, Heit JJ, Lansberg MG, et al. Hypoperfusion ratio predicts infarct growth during transfer for thrombectomy. Ann Neurol. 2018;84:616–20.
Guenego A, Marcellus DG, Martin BW, Christensen S, Albers GW, Lansberg MG, et al. Hypoperfusion intensity ratio is correlated with patient eligibility for thrombectomy. Stroke. 2019;50:917–22.
De Havenon A, Mlynash M, Kim-Tenser MA, Lansberg MG, Leslie-Mazwi T, Christensen S, et al. Results from DEFUSE 3: good collaterals are associated with reduced ischemic core growth but not neurologic outcome. Stroke. 2019;50:632–8.
Article PubMed PubMed Central Google Scholar
Kuroda S, Houkin K. Moyamoya disease: current concepts and future perspectives. Lancet Neurol. 2008;7:1056–66.
Sato Y, Kazumata K, Nakatani E, Houkin K, Katatani Y. Characteristics of moyamoya disease based on National registry data in Japan. Stroke. 2019;50:1973–80.
Lu J, Zhao Y, Li M, Ma L, Chen Y, Wang R, et al. Clinical implications of the “brush sign” in susceptibility-weighted imaging for moyamoya disease. Cerebrovasc Dis. 2021;50:147–55.
Saposnik G, Bushnell C, Coutinho JM, Field TS, Furie KL, Galadanci N, et al. Diagnosis and management of cerebral venous thrombosis: a scientific statement from the American Heart Association. Stroke. 2024;55:77–90.
Alet M, Ciardi C, Aleman A, Bandeo L, Bonardo P, Cea C, et al. Cerebral venous thrombosis in Argentina: clinical presentation, predisposing factors, outcomes and literature review. J Stroke Cerebrovasc Dis. 2020;29:105145.
留言 (0)